Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 26, 2025, titled "Press Release for Unaudited Financial Results for the quarter ended June 30, 2025".
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 26, 2025, titled "Press Release for Unaudited Financial Results for the quarter ended June 30, 2025".